← European Medicine Shortage Tracker · all medicines

Eptakog alfa (aktiverad) shortage — availability across Europe

Eptakog alfa (aktiverad) has no active shortage reports in the tracked registers right now — recent history below.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Discontinued  ATC — · also listed as: eptakog alfa (aktiverad) · data refreshed 7 August 2026

Key facts

No register currently lists an active availability issue for Eptakog alfa (aktiverad). The most recent report in the tracked registers dates to 2027-01-14 and is closed; this page updates automatically if a new report is filed.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇸🇪 SwedenDiscontinued
NovoSeven 8 mg Pulver och vätska till injektionsvätska, lösning
2027-01-14
Alternatives: Alternative(s) available — see the national register.
register ↗

Full report history (1 register entry)

Every individual register entry for Eptakog alfa (aktiverad) in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇸🇪 SENovoSeven 8 mg Pulver och vätska till injektionsvätska, lösningDiscontinued2027-01-14

Frequently asked

Is Eptakog alfa (aktiverad) currently in shortage in Europe?

No. As of 7 August 2026, none of the 10 tracked official registers list an active availability issue for Eptakog alfa (aktiverad).

Where does this Eptakog alfa (aktiverad) availability data come from?

Directly from the official medicines-agency register that lists Eptakog alfa (aktiverad): Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Eptakog alfa (aktiverad) — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/eptakog-alfa-aktiverad/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Eptakog alfa (aktiverad) availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/eptakog-alfa-aktiverad/">Eptakog alfa (aktiverad) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Eptakog alfa (aktiverad): availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.